{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:08Z","timestamp":1792788008410,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Fund for Youths of Jiangxi Province","award":["20224BAB216067"],"award-info":[{"award-number":["20224BAB216067"]}]},{"name":"Youth Program of Ganzhou Sci-Tech and Medical Joint Program","award":["2025YLCE0054"],"award-info":[{"award-number":["2025YLCE0054"]}]},{"name":"Regional Programs of the National Natural Science Foundation of China","award":["82360507"],"award-info":[{"award-number":["82360507"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Regional Programs of the National Natural Science Foundation of China","award":["82560474"],"award-info":[{"award-number":["82560474"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Regional Programs of the National Natural Science Foundation of China","award":["82560461"],"award-info":[{"award-number":["82560461"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08557-5","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:36:31Z","timestamp":1783352191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["KLF5-driven TAZ\u2013FASN signaling reprograms fatty acid metabolism to support Treg differentiation in lung cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongxiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxa","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfeiyang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"8557_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"8557_CR2","doi-asserted-by":"publisher","first-page":"217241","DOI":"10.1016\/j.canlet.2024.217241","volume":"604","author":"X Gang","year":"2024","unstructured":"Gang X, Yan J, Li X, Shi S, Xu L, Liu R, et al. Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions. Cancer Lett. 2024;604:217241.","journal-title":"Cancer Lett"},{"key":"8557_CR3","doi-asserted-by":"publisher","first-page":"1137224","DOI":"10.3389\/fonc.2023.1137224","volume":"13","author":"H Huang","year":"2023","unstructured":"Huang H, Zhong P, Zhu X, Fu S, Li S, Peng S, et al. Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC. Front Oncol. 2023;13:1137224.","journal-title":"Front Oncol"},{"key":"8557_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/1759-7714.14271","volume":"13","author":"Y Long","year":"2022","unstructured":"Long Y, Xiong Q, Song Q, Li Y, Li X, Qin B, et al. Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib. Thorac Cancer. 2022;13:394\u2013403.","journal-title":"Thorac Cancer"},{"key":"8557_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1200\/JCO.21.01845","volume":"40","author":"A Passaro","year":"2022","unstructured":"Passaro A, Brahmer J, Antonia S, Mok T, Peters S. Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. J Clin Oncol. 2022;40:598\u2013610.","journal-title":"J Clin Oncol"},{"key":"8557_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergen.2025.03.004","volume":"294\u2013295","author":"S Narote","year":"2025","unstructured":"Narote S, Desai SA, Patel VP, Deshmukh R, Raut N, Dapse S. Identification of new immune target and signaling for cancer immunotherapy. Cancer Genet. 2025;294\u2013295:57\u201375.","journal-title":"Cancer Genet"},{"key":"8557_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"8557_CR8","doi-asserted-by":"publisher","first-page":"684098","DOI":"10.3389\/fonc.2021.684098","volume":"11","author":"DR Principe","year":"2021","unstructured":"Principe DR, Chiec L, Mohindra NA, Munshi HG. Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer. Front Oncol. 2021;11:684098.","journal-title":"Front Oncol"},{"key":"8557_CR9","doi-asserted-by":"crossref","unstructured":"Aktepe N, Baran A, Keskin C. Cytotoxic and antimicrobial analysis of biosynthesized selenium nanoparticles from Solanum tuberosum peels. Int J Agric Environ Food Sci. 2025.","DOI":"10.31015\/2025.2.29"},{"key":"8557_CR10","first-page":"68","volume":"11","author":"BALNAN \u0130","year":"2026","unstructured":"BALNAN \u0130. Banana Peel\u2013Assisted Synthesis of ZnS and 5 mol % Mg-Doped ZnS for Photocatalytic Degradation of Congo Red. MAS J Appl Sci. 2026;11:68\u201380.","journal-title":"MAS J Appl Sci"},{"key":"8557_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41423-023-01011-2","volume":"20","author":"E Grajchen","year":"2023","unstructured":"Grajchen E, Loix M, Baeten P, Corte-Real BF, Hamad I, Vanherle S, et al. Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity. Cell Mol Immunol. 2023;20:666\u201379.","journal-title":"Cell Mol Immunol"},{"key":"8557_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H, Franco F, Tsui YC, Xie X, Trefny MP, Zappasodi R, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21:298\u2013308.","journal-title":"Nat Immunol"},{"key":"8557_CR13","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1038\/s41598-017-05556-x","volume":"7","author":"ME Muroski","year":"2017","unstructured":"Muroski ME, Miska J, Chang AL, Zhang P, Rashidi A, Moore H, et al. Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate. Sci Rep. 2017;7:5790.","journal-title":"Sci Rep"},{"key":"8557_CR14","doi-asserted-by":"publisher","first-page":"E6546","DOI":"10.1073\/pnas.1720113115","volume":"115","author":"I Pacella","year":"2018","unstructured":"Pacella I, Procaccini C, Focaccetti C, Miacci S, Timperi E, Faicchia D, et al. Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth. Proc Natl Acad Sci U S A. 2018;115:E6546\u201355.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8557_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","volume":"591","author":"SA Lim","year":"2021","unstructured":"Lim SA, Wei J, Nguyen TM, Shi H, Su W, Palacios G, et al. Lipid signalling enforces functional specialization of T(reg) cells in tumours. Nature. 2021;591:306\u201311.","journal-title":"Nature"},{"key":"8557_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","volume":"53","author":"S Kumagai","year":"2020","unstructured":"Kumagai S, Togashi Y, Sakai C, Kawazoe A, Kawazu M, Ueno T, et al. An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells. Immunity. 2020;53:187\u2013e203188.","journal-title":"Immunity"},{"key":"8557_CR17","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41598-023-28987-1","volume":"13","author":"T Kasuya","year":"2023","unstructured":"Kasuya T, Tanaka S, Tamura J, Etori K, Shoda J, Hattori K, et al. Epithelial cell-derived cytokine TSLP activates regulatory T cells by enhancing fatty acid uptake. Sci Rep. 2023;13:1653.","journal-title":"Sci Rep"},{"key":"8557_CR18","doi-asserted-by":"crossref","unstructured":"Gong L, Luo J, Zhang Y, Yang Y, Li S, Fang X, et al. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. Nat Commun. 2023;14:1912.","DOI":"10.1038\/s41467-023-37614-6"},{"key":"8557_CR19","doi-asserted-by":"publisher","first-page":"e2404734","DOI":"10.1002\/advs.202404734","volume":"12","author":"R Zi","year":"2025","unstructured":"Zi R, Zhao X, Liu L, Wang Y, Zhang R, Bian Z, et al. Metabolic-Immune Suppression Mediated by the SIRT1-CX3CL1 Axis Induces Functional Enhancement of Regulatory T Cells in Colorectal Carcinoma. Adv Sci (Weinh). 2025;12:e2404734.","journal-title":"Adv Sci (Weinh)"},{"key":"8557_CR20","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhou Y, Ren R, Lei J, Li Y. Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer. 2024;12.","DOI":"10.1136\/jitc-2024-008811"},{"key":"8557_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","volume":"5","author":"YG Jeon","year":"2023","unstructured":"Jeon YG, Kim YY, Lee G, Kim JB. Physiological and pathological roles of lipogenesis. Nat Metab. 2023;5:735\u201359.","journal-title":"Nat Metab"},{"key":"8557_CR22","doi-asserted-by":"crossref","unstructured":"Methatham T, Nagai R, Aizawa K. A new hypothetical concept in metabolic understanding of cardiac fibrosis: glycolysis combined with TGF-beta and KLF5 signaling. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23084302"},{"key":"8557_CR23","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/cas.14910","volume":"112","author":"Y Luo","year":"2021","unstructured":"Luo Y, Chen C. The roles and regulation of the KLF5 transcription factor in cancers. Cancer Sci. 2021;112:2097\u2013117.","journal-title":"Cancer Sci"},{"key":"8557_CR24","doi-asserted-by":"publisher","first-page":"e17856","DOI":"10.1111\/jcmm.17856","volume":"28","author":"H Zhou","year":"2024","unstructured":"Zhou H, Chang J, Zhang J, Zheng H, Miao X, Mo H, et al. PRMT5 activates KLF5 by methylation to facilitate lung cancer. J Cell Mol Med. 2024;28:e17856.","journal-title":"J Cell Mol Med"},{"key":"8557_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.7150\/thno.63627","volume":"12","author":"CH Tung","year":"2022","unstructured":"Tung CH, Huang MF, Liang CH, Wu YY, Wu JE, Hsu CL, et al. alpha-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer. Theranostics. 2022;12:1173\u201386.","journal-title":"Theranostics"},{"key":"8557_CR26","doi-asserted-by":"publisher","first-page":"e2410263","DOI":"10.1002\/advs.202410263","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen C, Wang Z, Lin Q, Li M, Xu L, Fu Y, et al. NAT10 Promotes Gastric Cancer Liver Metastasis by Modulation of M2 Macrophage Polarization and Metastatic Tumor Cell Hepatic Adhesion. Adv Sci (Weinh). 2025;12:e2410263.","journal-title":"Adv Sci (Weinh)"},{"key":"8557_CR27","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.7150\/thno.82182","volume":"13","author":"Q Wu","year":"2023","unstructured":"Wu Q, Liu Z, Gao Z, Luo Y, Li F, Yang C, et al. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8(+) T-cell-dependent antitumor immunity. Theranostics. 2023;13:1381\u2013400.","journal-title":"Theranostics"},{"key":"8557_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BJ20080762","volume":"417","author":"MY Lee","year":"2009","unstructured":"Lee MY, Moon JS, Park SW, Koh YK, Ahn YH, Kim KS. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. Biochem J. 2009;417:313\u201322.","journal-title":"Biochem J"},{"key":"8557_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12943-018-0882-1","volume":"17","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhao H, Li Y, Xia D, Yang L, Ma Y, et al. The role of YAP\/TAZ activity in cancer metabolic reprogramming. Mol Cancer. 2018;17:134.","journal-title":"Mol Cancer"},{"key":"8557_CR30","doi-asserted-by":"publisher","first-page":"1522705","DOI":"10.3389\/fcell.2025.1522705","volume":"13","author":"AO Ajongbolo","year":"2025","unstructured":"Ajongbolo AO, Langhans SA. YAP\/TAZ-associated cell signaling - at the crossroads of cancer and neurodevelopmental disorders. Front Cell Dev Biol. 2025;13:1522705.","journal-title":"Front Cell Dev Biol"},{"key":"8557_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3803\/EnM.2025.2471","volume":"41","author":"H Huang","year":"2026","unstructured":"Huang H, Chen J, Tao X, Zhong P, Meng Y, Peng S, et al. TAZ WW Domain-Mediated Regulation of Gluconeogenesis and Tumorigenesis in Hepatocellular Carcinoma through Interaction with the Glucocorticoid Receptor. Endocrinol Metab (Seoul). 2026;41:267\u201387.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"8557_CR32","doi-asserted-by":"crossref","unstructured":"Pocaterra A, Romani P, Dupont S. YAP\/TAZ functions and their regulation at a glance. J Cell Sci. 2020;133.","DOI":"10.1242\/jcs.230425"},{"key":"8557_CR33","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1038\/onc.2017.75","volume":"36","author":"A Noto","year":"2017","unstructured":"Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, et al. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP\/TAZ. Oncogene. 2017;36:4573\u201384.","journal-title":"Oncogene"},{"key":"8557_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5483\/BMBRep.2018.51.3.015","volume":"51","author":"MK Kim","year":"2018","unstructured":"Kim MK, Jang JW, Bae SC. DNA binding partners of YAP\/TAZ. BMB Rep. 2018;51:126\u201333.","journal-title":"BMB Rep"},{"key":"8557_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.intimp.2019.04.061","volume":"73","author":"NH Guo","year":"2019","unstructured":"Guo NH, Fu X, Zi FM, Song Y, Wang S, Cheng J. The potential therapeutic benefit of resveratrol on Th17\/Treg imbalance in immune thrombocytopenic purpura. Int Immunopharmacol. 2019;73:181\u201392.","journal-title":"Int Immunopharmacol"},{"key":"8557_CR36","doi-asserted-by":"crossref","unstructured":"Chen X, Liu H, Chen K, Guo Y, Mo T, Gao T. Inhibition of autophagy impairs free fatty acid-induced excessive lipid accumulation in hepatocellular carcinoma and hepatic cells. J Biosci. 2022;47.","DOI":"10.1007\/s12038-022-00257-8"},{"key":"8557_CR37","doi-asserted-by":"publisher","first-page":"102322","DOI":"10.1016\/j.redox.2022.102322","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen C, Chen J, Sang T, Peng H, Lin X, et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biol. 2022;52:102322.","journal-title":"Redox Biol"},{"key":"8557_CR38","doi-asserted-by":"publisher","first-page":"106941","DOI":"10.1016\/j.prostaglandins.2024.106941","volume":"176","author":"X Zheng","year":"2025","unstructured":"Zheng X, Zhou J, Nie S, Chen Y, Wei X, Zhang J, et al. TFAP2A activates CTHRC1 to influence the migration of lung adenocarcinoma cells by modulating fatty acid metabolism. Prostaglandins Other Lipid Mediat. 2025;176:106941.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"8557_CR39","doi-asserted-by":"publisher","first-page":"114624","DOI":"10.1016\/j.intimp.2025.114624","volume":"155","author":"M Hassan","year":"2025","unstructured":"Hassan M, Elzallat M, Mohammed DM, Balata M, El-Maadawy WH. Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases. Int Immunopharmacol. 2025;155:114624.","journal-title":"Int Immunopharmacol"},{"key":"8557_CR40","doi-asserted-by":"crossref","unstructured":"Blitek A, Szymanska M. Expression profiles of fatty acid transporters and the role of n-3 and n-6 polyunsaturated fatty acids in the porcine endometrium. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms252011102"},{"key":"8557_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cancergen.2025.10.101","volume":"298\u2013299","author":"M Wu","year":"2025","unstructured":"Wu M, Qian W, Xu M, Zhang J, Gao F, Chen L, et al. YME1L facilitates the development of non-small cell lung cancer by promoting activation of mitochondria-Galphai1-Akt pathway. Cancer Genet. 2025;298\u2013299:212\u201320.","journal-title":"Cancer Genet"},{"key":"8557_CR42","doi-asserted-by":"publisher","first-page":"205031212513411","DOI":"10.1177\/20503121251341114","volume":"13","author":"L Que","year":"2025","unstructured":"Que L, Liu Z, Wu Y, Luo L, Liang L. Identification of metabolism-associated molecular classification for effect and prognosis in lung adenocarcinoma based on multidatabases including the cancer genome atlas and gene expression omnibus. SAGE Open Med. 2025;13:20503121251341114.","journal-title":"SAGE Open Med"},{"key":"8557_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cancergen.2025.04.005","volume":"294\u2013295","author":"L Lu","year":"2025","unstructured":"Lu L, Chen L, Gao F, Xu C, Ni C, Qian W. Rab5if is a potential therapeutic target of NSCLC. Cancer Genet. 2025;294\u2013295:123\u201335.","journal-title":"Cancer Genet"},{"key":"8557_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cancergen.2025.10.002","volume":"298\u2013299","author":"J Jiang","year":"2025","unstructured":"Jiang J, Chen X, Dong X, Wang Y, Liu J, Liu T, et al. RNF121 promotes the proliferation, migration, and invasion of lung cancer cell lines. Cancer Genet. 2025;298\u2013299:193\u20137.","journal-title":"Cancer Genet"},{"key":"8557_CR45","doi-asserted-by":"crossref","unstructured":"Rebuzzi SE, Zullo L, Rossi G, Grassi M, Murianni V, Tagliamento M, et al. Novel emerging molecular targets in non-small cell lung cancer. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22052625"},{"key":"8557_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3892\/etm.2024.12397","volume":"27","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yu B, Qu M, Liu F, Wu X. Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer. Exp Ther Med. 2024;27:109.","journal-title":"Exp Ther Med"},{"key":"8557_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCRESAHA.115.306383","volume":"118","author":"K Drosatos","year":"2016","unstructured":"Drosatos K, Pollak NM, Pol CJ, Ntziachristos P, Willecke F, Valenti MC, et al. Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function. Circ Res. 2016;118:241\u201353.","journal-title":"Circ Res"},{"key":"8557_CR48","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/CAD.0000000000001515","volume":"34","author":"Q Zuo","year":"2023","unstructured":"Zuo Q, Xu Q, Li Z, Luo D, Peng H, Duan Z. Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription. Anticancer Drugs. 2023;34:1171\u201382.","journal-title":"Anticancer Drugs"},{"key":"8557_CR49","doi-asserted-by":"publisher","first-page":"12642","DOI":"10.1111\/jcmm.15832","volume":"24","author":"W Xia","year":"2020","unstructured":"Xia W, Bai H, Deng Y, Yang Y. PLA2G16 is a mutant p53\/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer. J Cell Mol Med. 2020;24:12642\u201355.","journal-title":"J Cell Mol Med"},{"key":"8557_CR50","doi-asserted-by":"publisher","first-page":"107339","DOI":"10.5306\/wjco.v16.i7.107339","volume":"16","author":"S Cakal","year":"2025","unstructured":"Cakal S, Er Urganci B, Simsek S. Key players in the breast cancer microenvironment: From fibroblasts to immune cells. World J Clin Oncol. 2025;16:107339.","journal-title":"World J Clin Oncol"},{"key":"8557_CR51","doi-asserted-by":"publisher","first-page":"1614815","DOI":"10.3389\/fimmu.2025.1614815","volume":"16","author":"Q Ma","year":"2025","unstructured":"Ma Q, Kang R, Xu R, Guan Y, Chang S, Li S. Crosstalk between stromal, immune, and ovarian cancer cells in lipid-rich tumor microenvironment exhibits proliferative features. Front Immunol. 2025;16:1614815.","journal-title":"Front Immunol"},{"key":"8557_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.it.2012.08.005","volume":"34","author":"PA Savage","year":"2013","unstructured":"Savage PA, Malchow S, Leventhal DS. Basic principles of tumor-associated regulatory T cell biology. Trends Immunol. 2013;34:33\u201340.","journal-title":"Trends Immunol"},{"key":"8557_CR53","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.4110\/in.2023.23.e4","volume":"23","author":"GR Lee","year":"2023","unstructured":"Lee GR. Molecular Mechanisms of T Helper Cell Differentiation and Functional Specialization. Immune Netw. 2023;23:e4.","journal-title":"Immune Netw"},{"key":"8557_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2020.06.020","volume":"53","author":"N Khatwani","year":"2020","unstructured":"Khatwani N, Turk MJ. Oncogenes Feed Treg Cells without Calling CD8s to the Table. Immunity. 2020;53:13\u20135.","journal-title":"Immunity"},{"key":"8557_CR55","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/iub.1233","volume":"65","author":"SM Diakiw","year":"2013","unstructured":"Diakiw SM, D\u2019Andrea RJ, Brown AL. The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation. IUBMB Life. 2013;65:999\u20131011.","journal-title":"IUBMB Life"},{"key":"8557_CR56","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.21037\/atm-22-5438","volume":"10","author":"J Shen","year":"2022","unstructured":"Shen J, Huang J, Huang Y, Chen Y, Li J, Luo P, et al. Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism. Ann Transl Med. 2022;10:1337.","journal-title":"Ann Transl Med"},{"key":"8557_CR57","doi-asserted-by":"crossref","unstructured":"Papavassiliou KA, Marinos G, Papavassiliou AG. Targeting YAP\/TAZ in combination with PD-L1 immune checkpoint inhibitors in non-small cell lung cancer (NSCLC). Cells. 2023;12.","DOI":"10.3390\/cells12060871"},{"key":"8557_CR58","doi-asserted-by":"publisher","first-page":"13529","DOI":"10.1073\/pnas.1917969117","volume":"117","author":"J Kim","year":"2020","unstructured":"Kim J, Kwon H, Shin YK, Song G, Lee T, Kim Y, et al. MAML1\/2 promote YAP\/TAZ nuclear localization and tumorigenesis. Proc Natl Acad Sci U S A. 2020;117:13529\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8557_CR59","doi-asserted-by":"publisher","first-page":"118330","DOI":"10.1016\/j.ejmech.2025.118330","volume":"302","author":"F Chen","year":"2026","unstructured":"Chen F, Su J, Liu Y, Zhang Z, Li S, Yuan Y, et al. Targeting YAP\/TAZ-TEAD and their protein-protein interaction for precision cancer therapy. Eur J Med Chem. 2026;302:118330.","journal-title":"Eur J Med Chem"},{"key":"8557_CR60","doi-asserted-by":"publisher","first-page":"13955","DOI":"10.2147\/IJN.S551712","volume":"20","author":"M Li","year":"2025","unstructured":"Li M, Hasan I, Zhang L, Peng T, Guo B, Wang Z. Photothermal and Combinatory Therapy as an Emerging Therapeutic Paradigm of Breast Cancer Treatment. Int J Nanomed. 2025;20:13955\u201388.","journal-title":"Int J Nanomed"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08557-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:03:20Z","timestamp":1790813000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08557-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8557"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08557-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involving human participants was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. The use of clinical lung cancer and paired normal tissues was approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (Approval No. (2024) CDYFYYLK (08\u2013056)), and written informed consent was obtained from all patients prior to sample collection. All animal experiments were performed in compliance with the National Guidelines for the Care and Use of Laboratory Animals issued by the Ministry of Science and Technology of China (2006) and the Guiding Opinions on the Kind Treatment of Laboratory Animals (MOST, 2006). The study protocol was approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital of Nanchang University (Approval No. CDYFY-IACUC-2023022040) and reported in accordance with the ARRIVE 2.0 guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1226"}}